It was a pleasure to co-host the “NewCo & Out-Licensing” forum with Jones Day and IntelliPro bringing together leaders from biotech, pharma, and investment to explore cross-border collaboration and global expansion strategies.
🙏 Special thanks to Zhui Chen and Alex J. Zhang for their insightful opening remarks on behalf of AHEA, setting the stage for an afternoon filled with strategic discussion and visionary thinking.
💬 Session Highlights:
🔹 Panel Discussion I: Out-Licensing by Chinese Biotechs to Pharma MNCs
🔹 We explored key deal drivers, considerations for both sides, and what it takes to execute successful cross-border out-licensing.
🔹 Moderator: Tony Chen (Jones Day Shanghai Office)
🔹 Panelists: Ross Keene (Jones Day), Dr. Oliver Schlüter (Dermaliq), Ming Fang (GSK), Wei Liu (Hengrui), Zikai X. (ImmuneOnco), Megan X.(Novartis), Harm-Jan Borgeld (Roche), Dr. Tong Zhang (VelaVigo), and Lihua Yu (WuXi Biologics).
🚀 Roadshow:
We featured cutting-edge platforms from: CARsgen Therapeutics, CureMark®, Dermaliq Therapeutics, Inc., Grit Biotechnology, Hua Medicine, OneTwenty Therapeutics , and Shengyuan WenDing.🔹 Panel Discussion II: NewCo Model & Trends in Biopharma Investment
🔹 A forward-looking conversation on NewCo structures, VC/PE engagement, and IP strategy for cross-border growth.
🔹 Moderator: Angel Huang (Jones Day Mainland China offices)
🔹 Panelists: Dr. Xiaojin An (Jones Day), Gen Li (China Grand), Dr. Ning Li (Gaorong Ventures), Jieyu Zou (Asia Ventures), and Jayson Lee (LongRiver Investments).
🙏Thanks again to all speakers, partners, and participants for contributing to a thought-provoking and high-impact event!
On January 11, 2026, during J.P. Morgan Healthcare Week, the American Healthcare Executive Association (AHEA) convened senior leaders from across global biopharma in San Francisco for the 2026 Global Biopharma Leadership Forum — creating a trusted platform for strategic exchange ahead of the industry’s most influential gathering of the year.
On January 11, 2026, during J.P. Morgan Healthcare Week, American Healthcare Executive Association was proud to partner with bioSeedin to co-host the BIOseedin Winter Innovation Partnering Summit in San Francisco.
On June 15, 2025, AHEA was proud to co-host the Global Biopharma Leadership Forum at Harvard Medical School, alongside IntelliPro, BayHelix Group, CSSA@HMS, and MSQ Ventures, with generous support from BioCentury and UHY.
On June 14, 2025, during the BIO International Convention, AHEA was honored to co-host the Executive Workshop at PwC Boston Headquarters, in partnership with PwC, IntelliPro, BayHelix, and MSQ Ventures.
It was a pleasure to co-host the “NewCo & Out-Licensing” forum with Jones Day and IntelliPro bringing together leaders from biotech, pharma, and investment to explore cross-border collaboration and global expansion strategies.
We are thrilled to announce the resounding success of the AHEA Summit 2024, held in conjunction with JPM2024. This event has marked a significant milestone in our journey towards healthcare innovation and global collaboration.
contact@ahea.io